Results 211 to 220 of about 172,503 (288)

Too Complex to Control? How Firms Navigate Scope 3 Governance Under Institutional Uncertainty

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT As Scope 3 emissions make up the largest share of many firms' carbon footprints, firms face growing pressure to manage emissions beyond their direct control. Ongoing revisions of the CSRD, the GHG Protocol, and the SBTi Net‐Zero Standard further increase regulatory and methodological uncertainty.
Victoria Fohrer   +2 more
wiley   +1 more source

Taking Fuel From the Fire: Regulating the Introduction of Rape Myth Infused and Irrelevant Evidence About Complainants in Rape Trials

open access: yesBehavioral Sciences &the Law, EarlyView.
ABSTRACT This article considers how victim‐blaming and stereotypical attitudes about appropriate victim behaviour can impact upon the operation of rape trials, particularly by prejudicing a complainant's testimony where s/he can be portrayed as having departed from the stereotypical norm of a ‘real victim’.
Susan Leahy
wiley   +1 more source

Consumer Acceptance of Conversational Bots: Systematic Literature Review and Meta‐Analysis

open access: yesJournal of Consumer Behaviour, EarlyView.
ABSTRACT As consumers increasingly rely on conversational bots for daily tasks, evidence surrounding motivations for acceptance remains scattered. A systematic literature review (SLR) was conducted on 64 journal articles published between 2008 and 2024, of which 48 provided sufficient quantitative data for inclusion in a meta‐analysis.
Omar H. Fares, Seung Hwan (Mark) Lee
wiley   +1 more source

Measuring Consumer Aversion Toward AI in Marketing Communication and Assessing Its Relationship to Brand Perceptions and Purchase Intention

open access: yesJournal of Consumer Behaviour, EarlyView.
ABSTRACT Some consumers exhibit aversion toward artificial intelligence (AI), particularly when it is embedded in persuasive marketing communication (MarCom). Here, we developed and validated a measure of consumer aversion to AI in MarCom and examined its downstream consequences for brand perceptions and purchase intention.
Louvins Pierre   +2 more
wiley   +1 more source

Drug Critical Limits for Urgent Physician Notification

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Critical limits represent quantitative decision thresholds for drugs that require immediate clinician notification and potential life‐saving intervention. United States hospitals lack a national standard for drug critical limits. We collected critical limits from 417 US hospitals across all 50 states and Washington, D.C.; of these, 411 maintained drug ...
Elina Kuang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy